» Articles » PMID: 24892919

Gender Differences in Ocular Blood Flow

Overview
Journal Curr Eye Res
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2014 Jun 4
PMID 24892919
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Gender medicine has been a major focus of research in recent years. The present review focuses on gender differences in the epidemiology of the most frequent ocular diseases that have been found to be associated with impaired ocular blood flow, such as age-related macular degeneration, glaucoma and diabetic retinopathy. Data have accumulated indicating that hormones have an important role in these diseases, since there are major differences in the prevalence and incidence between men and pre- and post-menopausal women. Whether this is related to vascular factors is, however, not entirely clear. Interestingly, the current knowledge about differences in ocular vascular parameters between men and women is sparse. Although little data is available, estrogen, progesterone and testosterone are most likely important regulators of blood flow in the retina and choroid, because they are key regulators of vascular tone in other organs. Estrogen seems to play a protective role since it decreases vascular resistance in large ocular vessels. Some studies indicate that hormone therapy is beneficial for ocular vascular disease in post-menopausal women. This evidence is, however, not sufficient to give any recommendation. Generally, remarkably few data are available on the role of sex hormones on ocular blood flow regulation, a topic that requires more attention in the future.

Citing Articles

Molecular Findings Before Vision Loss in the Streptozotocin-Induced Rat Model of Diabetic Retinopathy.

Moldovan M, Capras R, Pascalau R, Filip G Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852143 PMC: 11763991. DOI: 10.3390/cimb47010028.


Chorio-retinal vessel density in women affected by functional hypothalamic amenorrhea: a monocentric observational cross-sectional study to evaluate the impact of hypoestrogenism on chorio-retinal vascularization.

Diterlizzi A, Tropea A, Angelini E, Cestrone V, Fasciani R, Merola A Arch Gynecol Obstet. 2024; 310(4):2247-2252.

PMID: 38963584 PMC: 11393092. DOI: 10.1007/s00404-024-07603-1.


Optical Coherence Tomography Angiography Assessment of the Optic Nerve Head in Patients Hospitalized Due to COVID-19 Bilateral Pneumonia.

Kal M, Brzdek M, Zarebska-Michaluk D, Pinna A, Mackiewicz J, Odrobina D Medicina (Kaunas). 2024; 60(3).

PMID: 38541228 PMC: 10972053. DOI: 10.3390/medicina60030502.


The Appropriateness of Medical Devices Is Strongly Influenced by Sex and Gender.

Campesi I, Franconi F, Serra P Life (Basel). 2024; 14(2).

PMID: 38398743 PMC: 10890141. DOI: 10.3390/life14020234.


Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration.

Munuera I, Aragon-Navas A, Villacampa P, Gonzalez-Cela M, Subias M, Pablo L Int J Mol Sci. 2024; 25(1).

PMID: 38203183 PMC: 10779403. DOI: 10.3390/ijms25010009.


References
1.
Luksch A, Polska E, Imhof A, Schering J, Fuchsjager-Mayrl G, Wolzt M . Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003; 44(2):734-9. DOI: 10.1167/iovs.02-0177. View

2.
Kawasaki R, Yasuda M, Song S, Chen S, Jonas J, Wang J . The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010; 117(5):921-7. DOI: 10.1016/j.ophtha.2009.10.007. View

3.
Tormene D, Ferri V, Carraro S, Simioni P . Gender and the risk of venous thromboembolism. Semin Thromb Hemost. 2011; 37(3):193-8. DOI: 10.1055/s-0031-1273083. View

4.
Wong T, Klein R . Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol. 2002; 13(3):142-6. DOI: 10.1097/00055735-200206000-00002. View

5.
Rothova A, Berendschot T, Probst K, van Kooij B, Baarsma G . Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology. 2004; 111(5):954-9. DOI: 10.1016/j.ophtha.2003.09.031. View